Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Novel, disease-modifying treatments for neuropathic pain are urgently required. The cellular immune response to nerve injury represents a promising target for therapeutic development. Recently, the role of natural killer (NK) cells in both the central and peripheral nervous system disease has been the subject of growing interest. In this opinion piece, we set out the case for NK cell-based intervention as a promising avenue for development in the management of neuropathic pain. We explore the potential cellular and molecular targets of NK cells in the peripheral nervous system by contrasting with their reported functional roles in central nervous system diseases, and suggest strategies for utilizing the beneficial functions of NK cells and immune-based therapeutics in the context of neuropathic pain.


Journal article


Trends in Neurosciences



Publication Date